Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Pediatr ; 254: 75-82.e4, 2023 03.
Article de Anglais | MEDLINE | ID: mdl-36265573

RÉSUMÉ

OBJECTIVE: To describe the clinical features and course of liver involvement in a cohort of patients with Niemann-Pick type C disease (NP-C), a severe lysosomal storage disorder. STUDY DESIGN: Patients with genetically confirmed NP-C (NPC1, n = 31; NPC2, n = 3) and liver involvement before age 6 months were retrospectively included. Clinical, laboratory test, and imaging data were collected until the last follow-up or death; available liver biopsy specimens were studied using anti-CD68 immunostaining. RESULTS: At initial evaluation (median age, 17 days of life), all patients had hepatomegaly, 33 had splenomegaly, and 30 had neonatal cholestasis. Portal hypertension and liver failure developed in 9 and 4 patients, respectively. Liver biopsy studies, performed in 16 patients, revealed significant fibrosis in all 16 and CD68+ storage cells in 15. Serum alpha-fetoprotein concentration measured in 21 patients was elevated in 17. Plasma oxysterol concentrations were increased in the 16 patients tested. Four patients died within 6 months of life, including 3 from liver involvement. In patients who survived beyond age 6 months (median follow-up, 6.1 years), cholestasis regressed in all, and portal hypertension regressed in all but 1; 25 patients developed neurologic involvement, which was fatal in 16 patients. CONCLUSIONS: Liver involvement in NP-C consisted of transient neonatal cholestasis with hepatosplenomegaly, was associated with liver fibrosis, and was responsible for death in 9% of patients. The combination of liver anti-CD68 immunostaining, serum alpha-fetoprotein measurement, and studies of plasma biomarkers should facilitate early identification of NP-C.


Sujet(s)
Maladies du foie , Maladie de Niemann-Pick de type C , Humains , Nourrisson , Nouveau-né , Alphafoetoprotéines/analyse , Cholestase/étiologie , Hépatomégalie/étiologie , Hypertension portale/étiologie , Maladie de Niemann-Pick de type C/sang , Maladie de Niemann-Pick de type C/complications , Maladie de Niemann-Pick de type C/diagnostic , Maladie de Niemann-Pick de type C/immunologie , Études rétrospectives , Maladies du foie/diagnostic , Maladies du foie/étiologie , Maladies du foie/immunologie , Maladies du foie/anatomopathologie , Foie/immunologie , Foie/anatomopathologie , Biopsie , Cirrhose du foie/étiologie , Marqueurs biologiques/sang , Oxystérols/sang
3.
J Pediatr ; 157(4): 623-9, 629.e1, 2010 Oct.
Article de Anglais | MEDLINE | ID: mdl-20553844

RÉSUMÉ

OBJECTIVE: To test the hypothesis that predisposition to childhood herpes simplex virus (HSV) type 1 encephalitis (HSE) may be determined in part by human genetic factors. STUDY DESIGN: A genetic epidemiologic survey of childhood HSE (onset at age 3 months to 15 years) over a 20-year period (1985-2004) was conducted throughout France (comprising 29 university hospital neuropediatric centers). A total of 85 children fulfilled the diagnostic criteria for inclusion. Family and personal histories were obtained by face-to-face interview for 51 patients. RESULTS: No familial cases of HSE were identified in our survey; however, a high proportion (20%) of the children interviewed had a relevant family history: parental consanguinity (12% of patients), early-onset herpetic keratitis in a first-degree relative (6%), or both (2%). The narrow window of high susceptibility to HSE before age 3 years (62% of patients) further indicates that predisposition to HSE is tightly age-dependent. CONCLUSIONS: This survey suggests that childhood HSE, although sporadic, may result from Mendelian predisposition (from autosomal recessive susceptibility in particular), at least in some children. There likely is incomplete penetrance, however, which may reflect, at least in part, the impact of age at the time of HSV-1 infection.


Sujet(s)
Encéphalite à herpès simplex/génétique , Encéphalite à herpès simplex/virologie , Variation génétique , Récepteur de type Toll-3/génétique , Aciclovir/usage thérapeutique , Adolescent , Facteurs âges , Âge de début , Antiviraux/usage thérapeutique , Enfant , Enfant d'âge préscolaire , Encéphalite à herpès simplex/traitement médicamenteux , Femelle , Prédisposition génétique à une maladie , Variation génétique/génétique , Humains , Nourrisson , Mâle , Facteurs de risque , Simplexvirus , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE